A Computationally-Inexpensive Strategy in CT Image Data Augmentation for Robust Deep Learning Classification in the Early Stages of an Outbreak.
Yikun HouMiguel Navarro-CiaPublished in: Biomedical physics & engineering express (2023)
Coronavirus disease 2019 (COVID-19) has spread globally for over three years, and chest computed tomography (CT) has been used to diagnose COVID-19 and identify lung damage in COVID-19 patients. Given its widespread, CT will remain a common diagnostic tool in future pandemics, but its effectiveness at the beginning of any pandemic will depend strongly on the ability to classify CT scans quickly and correctly when only limited resources are available, as it will happen inevitably again in future pandemics. Here, we resort into the transfer learning procedure and limited hyperparameters to use as few computing resources as possible for COVID-19 CT images classification. Advanced Normalisation Tools (ANTs) are used to synthesise images as augmented/independent data and trained on EfficientNet to investigate the effect of synthetic images. On the COVID-CT dataset, classification accuracy increases from 91.15% to 95.50% and Area Under the Receiver Operating Characteristic (AUC) from 96.40% to 98.54%. We also customise a small dataset to simulate data collected in the early stages of the outbreak and report an improvement in accuracy from 85.95% to 94.32% and AUC from 93.21% to 98.61%. This study provides a feasible Low-Threshold, Easy-To-Deploy and Ready-To-Use solution with a relatively low computational cost for medical image classification at an early stage of an outbreak in which scarce data are available and traditional data augmentation may fail. Hence, it would be most suitable for low-resource settings.
Keyphrases
- deep learning
- coronavirus disease
- computed tomography
- dual energy
- image quality
- sars cov
- contrast enhanced
- artificial intelligence
- convolutional neural network
- positron emission tomography
- machine learning
- electronic health record
- big data
- early stage
- respiratory syndrome coronavirus
- magnetic resonance imaging
- systematic review
- lymph node
- neoadjuvant chemotherapy
- high intensity
- pet ct